Pro-psychotic effects of synthetic cannabinoids: interactions with central dopamine, serotonin, and glutamate systems.

Abstract:

:An association between marijuana use and schizophrenia has been noted for decades, and the recent emergence of high-efficacy synthetic cannabinoids (SCBs) as drugs of abuse has lead to a growing number of clinical reports of persistent psychotic effects in users of these substances. The mechanisms underlying SCB-elicited pro-psychotic effects is unknown, but given the ubiquitous neuromodulatory functions of the endocannabinoid system, it seems likely that agonist actions at cannabinoid type-1 receptors (CB1Rs) might modulate the functions of other neurotransmitter systems known to be involved in schizophrenia. The present review surveys what is currently known about the interactions of CB1Rs with dopamine, serotonin, and glutamate systems, because all three of those neurotransmitters are well-established in the pathophysiology of schizophrenia and psychosis. Identification of molecular mechanisms underlying the pro-psychotic effects of SCB drugs of abuse may establish certain classes of these substances as particularly dangerous, guiding regulations to control availability of these drugs. Likewise, an understanding of the pharmacological interactions which lead to schizophrenia and psychosis subsequent to SCB exposure might guide the development of novel therapies to treat afflicted users.

journal_name

Drug Metab Rev

journal_title

Drug metabolism reviews

authors

Fantegrossi WE,Wilson CD,Berquist MD

doi

10.1080/03602532.2018.1428343

subject

Has Abstract

pub_date

2018-02-01 00:00:00

pages

65-73

issue

1

eissn

0360-2532

issn

1097-9883

journal_volume

50

pub_type

杂志文章,评审
  • Molecular and environmental causes of cancer.

    abstract::The multistep, clonal evolution model of cancer predicts fundamental mechanisms by which chemicals may influence the cancer process. These are illustrated by studies of the mechanisms of induction of carcinogenesis by estrogens and the inhibition of carcinogenesis by caloric restriction. ...

    journal_title:Drug metabolism reviews

    pub_type: 杂志文章,评审

    doi:10.1081/dmr-100100567

    authors: Barrett JC

    更新日期:2000-05-01 00:00:00

  • Macaque cytochromes P450: nomenclature, transcript, gene, genomic structure, and function.

    abstract::Monkeys, especially macaques, including cynomolgus (Macaca fascicularis) and rhesus monkeys (Macaca mulatta), are frequently used in drug metabolism studies due to their evolutionary closeness to humans. Recently, numerous cytochrome P450 (P450 or CYP) cDNAs have been identified and characterized in cynomolgus and rhe...

    journal_title:Drug metabolism reviews

    pub_type: 杂志文章,评审

    doi:10.3109/03602532.2010.549492

    authors: Uno Y,Iwasaki K,Yamazaki H,Nelson DR

    更新日期:2011-08-01 00:00:00

  • Drug-induced hyperbilirubinemia and the clinical influencing factors.

    abstract::Hyperbilirubinemia may accompany harmful effects such as jaundice, brain dysfunction, and pharmacokinetic alterations of drugs. Clinical drugs are the important causes of hyperbilirubinemia, especially for patients with certain pathologic conditions or with genetic variations. This article reviews hyperbilirubinemic p...

    journal_title:Drug metabolism reviews

    pub_type: 杂志文章,评审

    doi:10.1080/03602530802341133

    authors: Ah YM,Kim YM,Kim MJ,Choi YH,Park KH,Son IJ,Kim SG

    更新日期:2008-01-01 00:00:00

  • Pharmacogenetic screening of the gene deletion and duplications of CYP2D6.

    abstract::Cytochrome P450 (CYP) 2D6 is one of the most important enzymes involved in the metabolism of drugs. Multiple, clinically relevant, genetic variants of this gene have been identified and, among them, a gene deletion as well as multiplications of the gene. These large structural mutations in CYP2D6 occur at a relatively...

    journal_title:Drug metabolism reviews

    pub_type: 杂志文章,评审

    doi:10.1080/03602530600952206

    authors: Meijerman I,Sanderson LM,Smits PH,Beijnen JH,Schellens JH

    更新日期:2007-01-01 00:00:00

  • The fourth mammalian molybdenum enzyme mARC: current state of research.

    abstract::The mitochondrial amidoxime-reducing component (mARC) is a recently discovered molybdenum-containing enzyme in mammalians. Upon reconstitution with the electron transport proteins, cytochrome b(5) and its reductase, this molybdenum enzyme is capable of reducing N-hydroxylated compounds. It was named mARC because the N...

    journal_title:Drug metabolism reviews

    pub_type: 杂志文章,评审

    doi:10.3109/03602532.2011.608682

    authors: Havemeyer A,Lang J,Clement B

    更新日期:2011-11-01 00:00:00

  • Oxidant stress, mitochondria, and cell death mechanisms in drug-induced liver injury: lessons learned from acetaminophen hepatotoxicity.

    abstract::Hepatotoxicity is a serious problem during drug development and for the use of many established drugs. For example, acetaminophen overdose is currently the most frequent cause of acute liver failure in the United States and Great Britain. Evaluation of the mechanisms of drug-induced liver injury indicates that mitocho...

    journal_title:Drug metabolism reviews

    pub_type: 杂志文章,评审

    doi:10.3109/03602532.2011.602688

    authors: Jaeschke H,McGill MR,Ramachandran A

    更新日期:2012-02-01 00:00:00

  • Adverse pharmacokinetic interactions between illicit substances and clinical drugs.

    abstract::Adverse pharmacokinetic interactions between illicit substances and clinical drugs are of a significant health concern. Illicit substances are taken by healthy individuals as well as by patients with medical conditions such as mental illnesses, acquired immunodeficiency syndrome, diabetes mellitus and cancer. Many ind...

    journal_title:Drug metabolism reviews

    pub_type: 杂志文章,评审

    doi:10.1080/03602532.2019.1697283

    authors: Abbott KL,Flannery PC,Gill KS,Boothe DM,Dhanasekaran M,Mani S,Pondugula SR

    更新日期:2020-02-01 00:00:00

  • Quinone reductases multitasking in the metabolic world.

    abstract::The multiple functions of NAD(P)H:quinone oxidoreductase 1 (NQO1, DT-diaphorase) in the cell are reviewed. NQO1 has long been viewed as a chemoprotective enzyme involved in cellular defense against the electrophilic and oxidizing metabolites of xenobiotic quinones. It also participates in reduction of endogenous quino...

    journal_title:Drug metabolism reviews

    pub_type: 杂志文章,评审

    doi:10.1081/dmr-200033465

    authors: Ross D

    更新日期:2004-10-01 00:00:00

  • The role of aryl hydrocarbon receptor in the pathogenesis of cardiovascular diseases.

    abstract::Numerous experimental and epidemiological studies have demonstrated that polycyclic aromatic hydrocarbons (PAHs), which are major constituents of cigarette tobacco tar, are strongly involved in the pathogenesis of the cardiovascular diseases (CVDs). Knowing that PAH-induced toxicities are mediated by the activation of...

    journal_title:Drug metabolism reviews

    pub_type: 杂志文章,评审

    doi:10.1080/03602530600632063

    authors: Korashy HM,El-Kadi AO

    更新日期:2006-01-01 00:00:00

  • The pharmacokinetics of glycyrrhizic acid evaluated by physiologically based pharmacokinetic modeling.

    abstract::Glycyrrhizic acid is widely applied as a sweetener in food products and chewing tobacco. In addition, it is of clinical interest for possible treatment of chronic hepatitis C. In some highly exposed subjects, side effects such as hypertension and symptoms associated with electrolyte disturbances have been reported. To...

    journal_title:Drug metabolism reviews

    pub_type: 杂志文章,评审

    doi:10.1081/dmr-100104400

    authors: Ploeger B,Mensinga T,Sips A,Seinen W,Meulenbelt J,DeJongh J

    更新日期:2001-05-01 00:00:00

  • Pharmacology, drug efficacy, and the individual.

    abstract::The efficacy of drugs has to be demonstrated following the principal approach of statistical evaluation in controlled clinical trials. This scientifically and internationally accepted numerical approach has developed over the years to its importance, in contrast to the more pharmacologically attempt to extrapolate hum...

    journal_title:Drug metabolism reviews

    pub_type: 杂志文章,评审

    doi:10.1081/dmr-200033500

    authors: Hildebrandt AG

    更新日期:2004-10-01 00:00:00

  • Nano-hydroxyapatite use in dentistry: a systematic review.

    abstract::Nano-hydroxyapatite (nano-HA) is a material with multiple uses due to its biocompatibility and its resemblance to the nonorganic bone structure. It is used in various dental domains such as implantology, surgery, periodontology, esthetics and prevention. The aim of this study is to provide a wide understanding of nano...

    journal_title:Drug metabolism reviews

    pub_type: 杂志文章

    doi:10.1080/03602532.2020.1758713

    authors: Bordea IR,Candrea S,Alexescu GT,Bran S,Băciuț M,Băciuț G,Lucaciu O,Dinu CM,Todea DA

    更新日期:2020-05-01 00:00:00

  • Ros-induced histone modifications and their role in cell survival and cell death.

    abstract::Much is known about the distal DNA damage repair response. In particular, many of the enzymes and auxiliary proteins that participate in DNA repair have been characterized. In addition, knowledge of signaling pathways activated in response to DNA damage is increasing. In contrast, comparatively less is known of DNA da...

    journal_title:Drug metabolism reviews

    pub_type: 杂志文章,评审

    doi:10.1080/03602530600959649

    authors: Monks TJ,Xie R,Tikoo K,Lau SS

    更新日期:2006-01-01 00:00:00

  • Substrate selectivity of drug-metabolizing cytochrome P450s predicted from crystal structures and in silico modeling.

    abstract::Enormous efforts toward predicting the metabolic fate of a drug have been driven by the high attrition rate in drug development. To accelerate such efforts, it is critical to elucidate the molecular mechanisms of drug recognition by drug-metabolizing enzymes. Therefore, it is not surprising that an increasing number o...

    journal_title:Drug metabolism reviews

    pub_type: 杂志文章,评审

    doi:10.3109/03602532.2011.645581

    authors: Dong D,Wu B

    更新日期:2012-02-01 00:00:00

  • The role of hepatic and extrahepatic UDP-glucuronosyltransferases in human drug metabolism.

    abstract::At present, the methods and enzymology of the UDP-glucuronosyltransferases (UGTs) lag behind that of the cytochromes P450 (CYPs). About 15 human UGTs have been identified, and knowledge about their regulation, substrate selectivity, and tissue distribution has progressed recently. Alamethicin has been characterized as...

    journal_title:Drug metabolism reviews

    pub_type: 杂志文章,评审

    doi:10.1081/dmr-120000653

    authors: Fisher MB,Paine MF,Strelevitz TJ,Wrighton SA

    更新日期:2001-08-01 00:00:00

  • Metabolism of psilocybin and psilocin: clinical and forensic toxicological relevance.

    abstract::Psilocybin and psilocin are controlled substances in many countries. These are the two main hallucinogenic compounds of the "magic mushrooms" and both act as agonists or partial agonists at 5-hydroxytryptamine (5-HT)2A subtype receptors. During the last few years, psilocybin and psilocin have gained therapeutic releva...

    journal_title:Drug metabolism reviews

    pub_type: 杂志文章,评审

    doi:10.1080/03602532.2016.1278228

    authors: Dinis-Oliveira RJ

    更新日期:2017-02-01 00:00:00

  • Mechanisms of cell-cycle checkpoints: at the crossroads of carcinogenesis and drug discovery.

    abstract::Human tumors arise from multiple genetic changes that gradually transform growth-limited cells into highly invasive cells that are unresponsive to growth controls. The genetic evolution of normal cells into cancer cells is largely determined by the fidelity of DNA replication, repair, and division. Cell-cycle arrest i...

    journal_title:Drug metabolism reviews

    pub_type: 杂志文章,评审

    doi:10.1081/dmr-100102335

    authors: Flatt PM,Pietenpol JA

    更新日期:2000-08-01 00:00:00

  • The population approach to pharmacokinetic data analysis: rationale and standard data analysis methods.

    abstract::Population pharmacokinetics describe the typical relationships between physiology (both normal and disease altered) and pharmacokinetics, the interindividual variability in these relationships, and their residual intraindividual variability. Knowledge of population kinetics can help one to choose initial drug dosage, ...

    journal_title:Drug metabolism reviews

    pub_type: 杂志文章

    doi:10.3109/03602538409015063

    authors: Sheiner LB

    更新日期:1984-01-01 00:00:00

  • Structure, function, regulation and polymorphism and the clinical significance of human cytochrome P450 1A2.

    abstract::Human CYP1A2 is one of the major CYPs in human liver and metabolizes a number of clinical drugs (e.g., clozapine, tacrine, tizanidine, and theophylline; n > 110), a number of procarcinogens (e.g., benzo[a]pyrene and aromatic amines), and several important endogenous compounds (e.g., steroids). CYP1A2 is subject to rev...

    journal_title:Drug metabolism reviews

    pub_type: 杂志文章,评审

    doi:10.3109/03602530903286476

    authors: Zhou SF,Wang B,Yang LP,Liu JP

    更新日期:2010-05-01 00:00:00

  • Applications of surface-enhanced Raman scattering in advanced bio-medical technologies and diagnostics.

    abstract::In this review of the literature on surface-enhanced Raman scattering (SERS), we describe recent developments of this technique in the medical field. SERS has developed rapidly in the last few years as a result of the fascinating advancements in instrumentation and the ability to interpret complex Raman data using hig...

    journal_title:Drug metabolism reviews

    pub_type: 杂志文章,评审

    doi:10.3109/03602532.2013.873451

    authors: Nima ZA,Biswas A,Bayer IS,Hardcastle FD,Perry D,Ghosh A,Dervishi E,Biris AS

    更新日期:2014-05-01 00:00:00

  • Novel insights into the complex pharmacokinetics of voriconazole: a review of its metabolism.

    abstract::Voriconazole, a second-generation triazole frequently used for the prophylaxis and treatment of invasive fungal infections, undergoes complex metabolism mainly involving various (polymorphic) cytochrome P450 enzymes in humans. Although high inter- and intraindividual variability in voriconazole pharmacokinetics have b...

    journal_title:Drug metabolism reviews

    pub_type: 杂志文章,评审

    doi:10.1080/03602532.2019.1632888

    authors: Schulz J,Kluwe F,Mikus G,Michelet R,Kloft C

    更新日期:2019-08-01 00:00:00

  • Cytochrome P450: what have we learned and what are the future issues?

    abstract::The cytochrome P450 (P450) field came out of interest in the metabolism of drugs, carcinogens, and steroids, which remain major focal points. Over the years we have come to understand the P450 system components, the multiplicity of P450s, and many aspects of the regulation of the genes and also the catalytic mechanism...

    journal_title:Drug metabolism reviews

    pub_type: 杂志文章,评审

    doi:10.1081/dmr-120033996

    authors: Guengerich FP

    更新日期:2004-05-01 00:00:00

  • PharmGKB: understanding the effects of individual genetic variants.

    abstract::The Pharmacogenetics and Pharmacogenomics Knowledge Base (PharmGKB: http://www.pharmgkb.org) is devoted to disseminating primary data and knowledge in pharmacogenetics and pharmacogenomics. We are annotating the genes that are most important for drug response and present this information in the form of Very Important ...

    journal_title:Drug metabolism reviews

    pub_type: 杂志文章

    doi:10.1080/03602530802413338

    authors: Sangkuhl K,Berlin DS,Altman RB,Klein TE

    更新日期:2008-01-01 00:00:00

  • Novel pathways associated with quinone-induced stress in breast cancer cells.

    abstract::Hormone-dependent breast cancers that overexpress the ligand-binding nuclear transcription factor, estrogen receptor (ER), represent the most common form of breast epithelial malignancy. Exposure of breast epithelial cells to a redox-cycling and arylating quinone induces mitogen-activated protein kinase phosphorylatio...

    journal_title:Drug metabolism reviews

    pub_type: 杂志文章,评审

    doi:10.1080/03602530600959391

    authors: Benz CC,Atsriku C,Yau C,Britton D,Schilling B,Gibson BW,Baldwin MA,Scott GK

    更新日期:2006-01-01 00:00:00

  • Factors affecting metabolic activity of the intestinal microflora.

    abstract::1. The metabolic activity of the gastrointestinal microflora can be modified by numerous factors derived from the host, the host's environment, and the flora itself. 2. Marked differences exist in microbial composition and metabolism of the gut floras of different species of animal, and in the degree of colonization o...

    journal_title:Drug metabolism reviews

    pub_type: 杂志文章,评审

    doi:10.3109/03602538808994135

    authors: Rowland IR

    更新日期:1988-01-01 00:00:00

  • A review of public policy issues in promoting the development and commercialization of pharmacogenomic applications: challenges and implications.

    abstract::This article reviews the regulatory, social, policy, and other issues that will shape the development of pharmacogenomics applications. We identify and analyze 19 key public policy issues, ranging from the economic incentives for linked diagnostic-drug development, to the regulation of tests and drugs, and to privacy ...

    journal_title:Drug metabolism reviews

    pub_type: 杂志文章,评审

    doi:10.1080/03602530801952500

    authors: Garrison LP Jr,Carlson RJ,Carlson JJ,Kuszler PC,Meckley LM,Veenstra DL

    更新日期:2008-01-01 00:00:00

  • Synthetic cannabinoids pharmacokinetics and detection methods in biological matrices.

    abstract::Synthetic cannabinoids (SC), originally developed as research tools, are now highly abused novel psychoactive substances. We present a comprehensive systematic review covering in vivo and in vitro animal and human pharmacokinetics and analytical methods for identifying SC and their metabolites in biological matrices. ...

    journal_title:Drug metabolism reviews

    pub_type: 杂志文章,评审

    doi:10.3109/03602532.2015.1029635

    authors: Castaneto MS,Wohlfarth A,Desrosiers NA,Hartman RL,Gorelick DA,Huestis MA

    更新日期:2015-05-01 00:00:00

  • Computational predictions of the site of metabolism of cytochrome P450 2D6 substrates: comparative analysis, molecular docking, bioactivation and toxicological implications.

    abstract::Cytochrome P450 2D6 (CYP2D6) is a polymorphic enzyme responsible for metabolizing approximately 25% of all drugs. CYP2D6 is highly expressed in the brain and plays a role as the major CYP in the metabolism of numerous brain-penetrant drugs, including antipsychotics and antidepressants. CYP2D6 activity and inhibition h...

    journal_title:Drug metabolism reviews

    pub_type: 杂志文章,评审

    doi:10.3109/03602532.2015.1047026

    authors: Ford KA,Ryslik G,Sodhi J,Halladay J,Diaz D,Dambach D,Masuda M

    更新日期:2015-08-01 00:00:00

  • Predictive models for human glucose-6-phosphate dehydrogenase deficiency.

    abstract::The present paper has discussed available test systems for determination of the response of G-6-PD-deficient human erythrocytes to environmental agents. The limitations and advantages of each model have been examined, and the results of research using each model have been presented. The future development of suitable ...

    journal_title:Drug metabolism reviews

    pub_type: 杂志文章,评审

    doi:10.3109/03602538608998292

    authors: Horton HM,Calabrese EJ

    更新日期:1986-01-01 00:00:00

  • Regulatory functions of glutathione S-transferase P1-1 unrelated to detoxification.

    abstract::Glutathione S-transferase P1-1 (GSTP) is one member of the family of GSTs and is ubiquitously expressed in human tissues. The literature is replete with reports of high levels of GSTP linked either with cancer incidence or drug resistance, and yet no entirely cogent explanation for these correlations exists. The catal...

    journal_title:Drug metabolism reviews

    pub_type: 杂志文章,评审

    doi:10.3109/03602532.2011.552912

    authors: Tew KD,Townsend DM

    更新日期:2011-05-01 00:00:00